stockrowStrata Critical Medical, Inc.
SRTA Healthcare Medical Care Facilities
- Revenue
- +50.3%
- EPS
- −112.3%
- Free cash flow
- +121.3%
Quarter to September 2026, against a year earlier
Follow SRTA
Alert me
Strata Critical Medical, Inc. (SRTA) EV/Sales
As of 6 November 2026, Strata Critical Medical, Inc. (SRTA) trades at a EV/Sales of 1.6×. Over the past ten years it has ranged from −0.6× (January 2022) to 7.7× (November 2021); the current reading is higher than 78% of that period. That is above the Medical Care Facilities industry median of 1.3× and below the Healthcare sector median of 3.6×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 1.7× | 58.41% |
| FY2024 | 1.1× | 188.12% |
| FY2023 | 0.4× | 18.67% |
| FY2022 | 0.3× | (75.58%) |
| FY2021 | 1.3× | (81.49%) |
| FY2021 | 6.9× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Sep 2026 | 1.5× | (13.51%) |
| Jun 2026 | 1.7× | 29.42% |
| Mar 2026 | 1.3× | (23.00%) |
| Dec 2025 | 1.7× | (17.32%) |
| 21 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| CMPS COMPASS Pathways PLC Sponsored ADR compare | n/m |
| MCTA Charming Medical Limited compare | n/m |
| STLN Starling Oncology, Inc. compare | 0.7× |
| CYH Community Health Systems, Inc. compare | 0.8× |
| GMRS GMR Solutions Inc. compare | 0.8× |
| AUNA Auna S.A. compare | 0.9× |
| INNV InnovAge Holding Corp. compare | 1.1× |
| NUTX Nutex Health Inc. compare | 1.6× |
| SRTA Strata Critical Medical, Inc. | 1.6× |
| Medical Care Facilities industry median | 1.3× |
| Healthcare sector median | 3.6× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)